ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Dakota » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES HUGHES MD

Pulmonary Disease

3,171

$621K

333
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 72%

$196
Average prescription price

Avg: $200

MONICA PAULO MD

Pulmonary Disease

2,249

$323K

269
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 72%

$143
Average prescription price

Avg: $200

SOMSAK KRIENGKRAIRUT MD

Pulmonary Disease

2,012

$485K

230
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 72%

$241
Average prescription price

Avg: $200

ROBERT HUNG MD

Pulmonary Disease

1,578

$258K

228
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 72%

$164
Average prescription price

Avg: $200

NAEEM ADHAMI MD

Pulmonary Disease

1,511

$268K

258
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 72%

$178
Average prescription price

Avg: $200

UMAMAHESWAR MUDIREDDY MD

Pulmonary Disease

1,388

$319K

185
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 72%

$230
Average prescription price

Avg: $200

PEDRO MENDOZA M.D. FCCP

Pulmonary Disease

1,284

$391K

126
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 72%

$304
Average prescription price

Avg: $200

DONALD MATTHEES MD

Pulmonary Disease

834

$142K

145
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 72%

$170
Average prescription price

Avg: $200

MICHAEL BRIGGS MD

Pulmonary Disease

781

$144K

128
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 72%

$184
Average prescription price

Avg: $200

ANDREAS SARRIGIANNIDIS MD

Pulmonary Disease

720

$124K

120
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 72%

$173
Average prescription price

Avg: $200

WAYNE BREITWIESER MD

Pulmonary Disease

516

$83.6K

99
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 72%

$162
Average prescription price

Avg: $200

JEFFREY VERHEY MD

Pulmonary Disease

458

$156K

108
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 72%

$342
Average prescription price

Avg: $200

ARVIND BANSAL MD

Pulmonary Disease

419

$79.5K

95
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 72%

$190
Average prescription price

Avg: $200

NICHOLAS NEUMANN MD

Pulmonary Disease

208

$36.2K

12
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

91%
prescriptions for brand name drugs

Avg: 72%

$174
Average prescription price

Avg: $200

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank